Electrical Impedance Spectroscopy for Skin Cancer Detection
|Coordinator||SCIBASE AB - SciBase|
|Funding from Vinnova||SEK 3 860 000|
|Project duration||July 2015 - June 2017|
|Venture||The strategic innovation programme Electronic Components and Systems:|
Purpose and goal
Nevisense is the world´s first diagnostic support tool for non-visual detection of malignant melanoma. The goal for the project has been achieved by designing, producing and testing a miniaturized prototype with corresponding performance as Nevisense. Both phantom test and in-vivo test on skin show results comparable with Nevisense but at a much smaller form factor and with far less power consumption.
Expected results and effects
The outcome of the project is a prototype of a miniaturized Nevisense, a pen-like device for measurement of skin impedance. The prototype has been evaluated with electrical phantoms and in-vivo testing on skin. All tests show a performance comparable to the existing Nevisense but in a considerable smaller form factor with less power consumption. This will enable a modular concept that delivers Nevisense capability in an easy-to use form factor with improved integration to the physician workflow.
Planned approach and implementation
The project is conducted in cooperation between SciBase and the ICS-group at KTH. The cooperation has been successful and contributed to many synergy effects. SciBase has contributed with their clinical competence while the ICS-group have contributed with their unique competence within design of miniaturized electronics. The project has followed the time schedule and the test results are above expectation for all involved.